Stay updated on Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial page.

Latest updates to the Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe page’s revision label was updated from v3.6.5 to v3.6.6, indicating a newer version of the ClinicalTrials.gov entry. This appears to be a metadata update rather than a change to study details or visible content.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing the previous v3.6.4, indicating a small update to the page's underlying version.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page's revision line updated from Revision: v3.6.3 to Revision: v3.6.4, indicating a newer build/version of the page. This reflects an update to the page's revision history rather than a substantive content change.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page displays a new Revision: v3.6.3 tag, replacing the previous Revision: v3.6.0, signaling an update to the page or its underlying software.SummaryDifference0.1%

- Check86 days agoChange DetectedThe page now indicates that recruitment has ended and adds user-help sections to assist reading and joining the study. Formatting and revision labels were updated to reflect the new structure (Intervention/Treatment) and the latest revision version (v3.6.0).SummaryDifference0.4%

- Check93 days agoChange DetectedRevision: v3.5.5 is now displayed, replacing v3.5.4, signaling an updated entry. This appears to be a metadata revision rather than substantive changes to the study details.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial page.